Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Bankwell Financial Group
BWFG
$543M
| $5.87M | ﹤0.01% |
203,400
+9,000
| +5% | +$257K |
|
1752
Citizens & Northern Corp
CZNC
$466M
| $5.86M | ﹤0.01% |
207,400
-6,321
| -3% | -$165K |
|
|
CNCE
1753
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $5.85M | ﹤0.01% |
634,400
+16,610
| +3% | +$118K |
|
1754
Sempra
SRE
$56.5B
| $5.85M | ﹤0.01% |
77,202
-628,858
| -89% | -$46.1M |
|
|
GMLP
1755
DELISTED
Golar LNG Partners LP
GMLP
| $5.84M | ﹤0.01% |
660,400
+445,800
| +208% | +$4.24M |
|
1756
Ribbon Communications
RBBN
$377M
| $5.83M | ﹤0.01% |
1,879,600
-197,300
| -9% | -$785K |
|
1757
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $5.83M | ﹤0.01% |
118,658
+42,458
| +56% | +$2.08M |
|
1758
Cimpress
CMPR
$2.3B
| $5.83M | ﹤0.01% |
+46,321
| New | +$6.02M |
|
|
WPRT
1759
Westport Fuel Systems
WPRT
$33.4M
| $5.82M | ﹤0.01% |
245,665
+24,708
| +11% | +$633K |
|
1760
Liberty Energy
LBRT
$3.59B
| $5.82M | ﹤0.01% |
523,500
+476,200
| +1,007% | +$4.52M |
|
|
DRD
1761
DRDGold
DRD
$2.1B
| $5.81M | ﹤0.01% |
1,132,682
-75,200
| -6% | -$347K |
|
1762
NiSource
NI
$20.4B
| $5.8M | ﹤0.01% |
208,500
-885,400
| -81% | -$24.3M |
|
|
EXTN
1763
DELISTED
Exterran Corporation
EXTN
| $5.8M | ﹤0.01% |
741,100
-79,200
| -10% | -$735K |
|
1764
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $5.79M | ﹤0.01% |
+117,594
| New | +$5.79M |
|
|
BEST
1765
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $5.78M | ﹤0.01% |
52,010
+5,025
| +11% | +$551K |
|
1766
Vitamin Cottage Natural Grocers
NGVC
$648M
| $5.77M | ﹤0.01% |
584,265
+111,950
| +24% | +$1.03M |
|
1767
LSI Industries
LYTS
$913M
| $5.74M | ﹤0.01% |
948,471
+96,900
| +11% | +$533K |
|
1768
Groupon
GRPN
$875M
| $5.73M | ﹤0.01% |
119,940
-124,070
| -51% | -$6.88M |
|
1769
VanEck Semiconductor ETF
SMH
$72.4B
| $5.73M | ﹤0.01% |
+81,058
| New | +$5.31M |
|
1770
FS Bancorp
FSBW
$323M
| $5.67M | ﹤0.01% |
177,900
+43,200
| +32% | +$1.25M |
|
1771
Sociedad Química y Minera de Chile
SQM
$21.2B
| $5.67M | ﹤0.01% |
212,500
-48,200
| -18% | -$1.27M |
|
|
VG
1772
DELISTED
Vonage Holdings Corporation
VG
| $5.67M | ﹤0.01% |
+764,764
| New | +$6.61M |
|
1773
Inspire Medical Systems
INSP
$1.65B
| $5.66M | ﹤0.01% |
76,300
-4,100
| -5% | -$264K |
|
1774
Information Services Group
III
$250M
| $5.64M | ﹤0.01% |
2,231,064
+43,710
| +2% | +$104K |
|
1775
Saga Communications
SGA
$62.1M
| $5.64M | ﹤0.01% |
185,707
+13,800
| +8% | +$419K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.